Hayfin is pleased to announce that it has acquired a minority stake through its Private Equity Solutions (PES) strategy in Novétude Group, a new European healthcare education platform in partnership with Charterhouse Capital Partners. The Group will be built around Novétude Santé, which Charterhouse has owned and grown since 2020. Charterhouse will retain a majority stake in the new platform. 

Underpinned by significant industry tailwinds, there is strong sentiment that the Novétude Group is well-positioned to benefit from the large and growing market of European students enrolled in health and welfare studies at private education institutions and an ageing population in Europe, which is expected to drive increased demand for healthcare professionals and services. 

Gonzalo Erroz, Managing Director and Co-head of the Private Equity Solutions team at Hayfin, said: “Joining forces with Charterhouse is an exciting development as we continue to invest in exceptional opportunities in the European healthcare education sector. We are proud to contribute to Novétude’s mission of fostering excellence, accessibility and responsibility in professional training, ensuring healthcare specialists are supported throughout every stage of their careers.”  

Severin de Mortemart, Managing Director of the Private Equity Solutions team at Hayfin, said: “We are delighted to partner with Charterhouse and to leverage our position as an investor to support Novétude Group through their next stage of development, with the aim of helping to build one of the leading healthcare education platforms in Europe.” 

As an active investor in European mid-market companies via single-asset GP-led solutions, Hayfin’s PES strategy benefits from strong alignment of interest with sponsors and management teams that already own, operate and know the target businesses intimately. 

Private equity markets are at a watershed moment. A structural increase in competition, driven by dry powder accumulation, and capital market dislocation, are causing a significant decrease in exit liquidity and creating a scarcity of high-quality investment opportunities.

In our latest report, we uncover the following:

• How the single-asset secondary segment can account for 4%-8% of overall European PE exit activity, or €10bn-€20bn p.a., by 2025.

• Depending on pace of growth in the segment, concentrated GP-led deals could account for almost a fifth of sponsor-to-sponsor exit deal flow by 2025, effectively reallocating some of the top-quartile opportunities institutional investors previously accessed via direct managers to secondary capital pools.

• The drivers of the growth in Europe’s single-asset secondary space, from both a GP and LP perspective, including superior returns, a more attractive opportunity set at a time of heightened competition for assets, greater alignment between partners, better control over portfolio construction and preferable cashflow profile to a traditional primary buyout fund.